What the e-mail referred to is that if you compare Vioxx to a traditional pain reliever, you'll see a difference in clotting events. What he meant was that a misinterpretation of that difference would kill the drug, ... That e-mail was speculating that people would misinterpret it (the trial) as being a problem with Vioxx.
Quotes about vioxx (10 Quotes)
This is not a normal Vioxx case, which is about heart attacks and strokes being increased by the use of the drug, ... We plan on making it about the specifics of causation. ... This is a good case for us.
Whether it's Vioxx or Bextra or silicone implants, the rule now is 'Buyer Beware,' ... The drug and device companies own the FDA and it is the companies' profit potential that rules the review and approval process - except when the profit motive is overridden by the White House morality police, as with the morning-after pill.
The jury's decision confirms that there is no medical or scientific evidence showing short-term use of VIOXX increases the risk of heart attack and contributed in any way to the unfortunate death of Richard Irvin. Mr. Irvin only took VIOXX for less than a month. He suffered multiple long-standing risk factors for a heart attack including partially clogged arteries. Mr. Irvin would have suffered a heart attack when he did, whether he was taking VIOXX or not.
Merck acted responsibly, from researching Vioxx prior to approval in studies with almost 10,000 patients, to monitoring the medicine while it was on the market, to voluntarily withdrawing the medicine when it did. We based our decisions on the data from well controlled clinical trials.
Now is not the time to give greater protections to pharmaceutical companies that put unsafe drugs like Vioxx on the market. Such protections have nothing to do with the liability insurance crisis facing doctors and should be stripped from this bill.
There is no medical or scientific evidence that Vioxx contributed to Mr. Humeston's heart attack.
Cases we'll be looking at concern ingestion of Vioxx for 18 months or more by patients with limited heart risk factors.
When you have a massively prescribed and consumed drug like Vioxx, and if something goes wrong, you have a lot of potential for (liability) exposure. Vioxx has that kind of profile. Whether or not each and every drug will have that profile, it's hard to say.
Merck is satisfied with the jury verdict, ... There will be other VIOXX trials and we will vigorously defend them one by one over the coming years.